Syquant Capital Sas’s Abcellera Biologics Inc Position
Does Syquant Capital Sas own Abcellera Biologics Inc (ABCL)? Not currently — the last reported position was 70.0K shares worth $2M in Q2 2021; the fund’s latest 13F (Q2 2026) no longer reports it.
Position Value
$2M
Q2 2021
Shares
70.0K
% of Portfolio
+1.85%
Quarters Held
1
position exited
Position History ABCL
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2021 | 70.0K | $2M | +1.85% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Syquant Capital Sas’s full portfolio or all institutional holders of ABCL.